Barbara Handelin, Joan Bailey-Wilson, Alexander Wilson, Robin Toft, Thomas Caskey, Ferid Murad, Irma Gigli, David Lockhart, Peter Kim, David Robbins, CombiMatrix, Agilent Technologies | GenomeWeb


Barbara Handelin joined DNAPrint Pharmaceuticals, the newly organized subsidiary of DNAPrint Genomics, as director of diagnostics, the company said this week.

Since 1987, Handelin was director of the DNA Diagnostics Laboratory at Integrated Genetics (now Genzyme Genetics).

She earned her PhD at the Oregon Health Sciences University and the Massachusetts Institute of Technology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.